The drugmaker launched a campaign supporting its weight loss medication Contrave, all backed by a cover version of Lesley Gore’s 1963 hit “You Don’t Own Me.” ...
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other ...
Over the past few months, Blue Cross Blue Shield of Michigan, the state’s largest insurer, has scaled back on coverage of the weight-loss drugs Wegovy, Zepbound and Saxenda. These drugs are life ...
Further studies should include broader populations and head-to-head comparisons of bupropion/naltrexone with other active weight-loss agents ... of the two component drugs will require careful ...
The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...
The first tip came into West Tennessee law enforcement about two months ago: A resident in the area was selling cheap versions of Ozempic and other weight loss drugs. According to officials with ...
Studies suggest that the rise in usage of weight loss drugs like semaglutide is contributing to this change. The analysis was a cross-sectional study utilizing the Optum de-identified Market ...
Weight loss medications typically suppress a person ... Contrave belongs to a class of drugs known as bupropion/naltrexone. Bupropion is a type of antidepressant, whereas naltrexone is an ...
LONDON, Dec 18 (Reuters) - A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity pandemic” alongside other interventions ...